Veeva Compass and OpenData vs IQVIA
Former Director at Veeva Systems
inpractise.com/articles/veeva-compass-and-opendata-vs-iqvia
Veeva Compass and OpenData vs IQVIA(April 24, 2024)
Former Director at Veeva Systems
The executive is a Former Director at Veeva Systems and was responsible for building out Veeva Compass and other data products to compete with IQVIA. The executive has also been a customer of VeevaCRM as a sales rep for Merck for over a decade earlier in the career.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Could you give me a two-minute crash course on the litigation between Veeva and IQVIA? How far back does this go, and how do you frame the issue?
Yes, that's a good question. I'll try to do my best not to take up too much time. CRM is what field sales reps use to track how much of a drug they were using, according to IQVIA data. Peter mentioned that the IQVIA lawsuit stated that while you can use your data for field sales reps, any other data derived, such as metadata or derivative data from the IQVIA data, cannot be used. For example, if you wanted to aggregate data and draw a connection, such as if a field sales rep called on a doctor five times and then you wanted to correlate the performance of the Rx with that to show trended graphs, IQVIA says no. That data does not belong to you; you cannot connect that data with rep activity. Those have to stay separate; they are firewalled. This is critically useful information for the reps to show that their activity had a direct impact, and I can marry that up together. No, you have to keep those separate.
This is a snippet of the transcript, sign up to read more.
Related Content
Veeva Systems, IQVIA, & the Pharma Sales Flow
Former VP, Global Accounts at Veeva Systems
Clarivate: Management, M&A, & the One Clarivate Strategy
Former Vice President at Clarivate
Medpace: Culture, Org Structure & Business Development
Former Medical Director at Medpace
Evotec: Business Model, Sales Process & Org Structure
Former Business Development Executive at Evotec
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.